Ocata Therapeutics (OCAT) 10-Q 2015 Q2 Quarterly report

EXHIBIT 32.1

CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Paul K. Wotton, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Ocata Therapeutics, Inc. for the quarter ended June 30, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Ocata Therapeutics, Inc.

Dated: August 6, 2015	By:	/s/ Paul K. Wotton
		Paul K. Wotton
		Principal Executive Officer